secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001104659-26-007974
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth shareholders approve all seven proposals at 2026 Annual Meeting
---------------------------------------------------------------------------

- Directors elected: Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Yoav Shaked, Lawrence Leisure, Adam K. Stern.
- Ratified Kesselman & Kesselman (PwC) as auditor for FY 2026 (4,952,777 for, 17,242 against).
- Approved conversion of 25,605 Series D/D-1/D-2/D-3 preferred shares into 1,697,843 common shares, plus dividend and lock-up shares.
- Ratified issuance of common shares upon exercise of pre-funded warrants, warrants and RSUs from Twill acquisition.
- Approved increase in equity incentive plan by 500,000 shares and charter amendment allowing board to amend bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926007974/0001104659-26-007974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926007974/tm264437d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-007974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer